Craig Boerner

Roger Dmochowski, MD, with Female Pelvic Medicine and Reconstructive Surgery Urology fellows Stephanie Gleicher, MD, MPH, left, who graduates in June, and Rosa Park, MD.

Urology fellowship program celebrated after 20 years

The urology fellowship training program focused on women’s urologic health and reconstruction, known as Female Pelvic Medicine and Reconstructive Surgery, is celebrating its 20th anniversary and graduating its 20th fellow in June at Vanderbilt University Medical Center.

Study sheds light on drug’s impact on diabetes progression

A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.

VUMC joins group to accelerate implementation of research findings to improve patient outcomes

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.

Aspirnaut Sahra Hassan, right, a senior at Burlington High School in Burlington, Vermont, worked on mitochondrial DNA maintenance with postdoctoral scientist Iva Chitrakar, PhD.

VUMC’s Aspirnaut program to install science lab at Wynne High School in Arkansas

A chemical biology research lab fit for an academic medical center is being installed at Wynne High School (WHS) in Wynne, Arkansas, as part of a pilot project of Aspirnaut STEM pipeline at Vanderbilt University Medical Center.

Tennessee Advanced Communications Network expands to include state hospital systems

Vanderbilt University Medical Center to be an early adopter as a hospital system integrating the Tennessee Advanced Communications Network into its existing network of emergency providers for redundancy communications in the event of a disaster.

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

1 2 3 4 5 6 19